Cell-Free DNA Analysis of Fetal Aneuploidies in Early Pregnancy Loss

Products of conception samples are often collected and analyzed to try to determine the cause of an early pregnancy loss. However, sample collection may not always be possible, and maternal cell contamination and culture failure can affect the analysis. Cell-free DNA-based analysis of a blood sample...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2024-08, Vol.13 (15), p.4283
Main Authors: Kutteh, William H, Miller, Charles E, Park, John K, Corey, Victoria, Chavez, Mauro, Racicot, Karen, Alagia, 3rd, Damian P, Jinnett, Kristine N, Curnow, Kirsten, Dalton, Kristin, Bhatt, Sucheta, Keefe, David L
Format: Article
Language:English
Subjects:
Aneuploidy
Case reports
DNA
Genetic aspects
Genetic testing
Genomes
Gestational age
Health aspects
Health Insurance Portability & Accountability Act 1996-US
Laboratories
Miscarriage
Obstetrical research
Patients
Physiological aspects
Pregnancy
Sex chromosomes
Software
Ultrasonic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Products of conception samples are often collected and analyzed to try to determine the cause of an early pregnancy loss. However, sample collection may not always be possible, and maternal cell contamination and culture failure can affect the analysis. Cell-free DNA-based analysis of a blood sample could be used as an alternative method in early pregnancy loss cases to detect if aneuploidies were present in the fetus. : In this prospective study, blood samples from early pregnancy loss patients were analyzed for the presence of fetal aneuploidies using a modified version of a noninvasive prenatal testing assay for cell-free DNA analysis. Results from cell-free DNA analysis were compared against the gold standard, microarray analysis of products of conception samples. This study was registered with ClinicalTrials.gov, identifier: NCT04935138. : Of the 76 patient samples included in the final study cohort, 11 were excluded from performance calculations. The 65 patient samples included in the final analysis included 49 with an abnormal microarray result and 16 with a normal microarray result. Based on results from these 65 samples, the study found that genome-wide cell-free DNA analysis had a sensitivity of 73.5% with a specificity of 100% for the detection of fetal aneuploidies in early pregnancy loss cases. : This prospective study provides further support for the utility of cell-free DNA analysis in detecting fetal aneuploidies in early pregnancy loss cases. This approach could allow for a noninvasive method of investigating the etiology of miscarriages to be made available clinically.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm13154283